Actively Recruiting
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
Led by University of Florida · Updated on 2025-11-24
50000
Participants Needed
1
Research Sites
2556 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Alpha-1 Coded Testing (ACT) Study was established to study genetic testing and outcomes of individuals at risk for alpha-1 antitrypsin deficiency.
CONDITIONS
Official Title
The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Individuals of any age at risk for alpha-1 antitrypsin deficiency based on symptoms or family genetic risk
You will not qualify if you...
- People who have already completed genotype and alpha-1 antitrypsin level testing with a qualified result
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Florida
Gainesville, Florida, United States, 32610
Actively Recruiting
Research Team
M
Michelle Owens, RN, BSN
CONTACT
A
Allison Faunce, B.A.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here